Dexion Capital is an alternatives investment business focused on the selection, structuring and distribution of alternative asset strategies.

Dexion Capital has more than 15 years’ experience in raising funds for a broad range of alternative strategies in public and private capital markets. Dexion Capital represents leading and specialist asset managers/issuers as a third-party distributor and also acts in a partnership role, white-labelling funds. Through its alternative UCITS platform, Dexion Liquid Strategies, Dexion Capital is able to provide a range of liquid alternative investment strategies to its investor base in the UK, and selectively in Europe.

Dexion is owned by Fidante Partners the boutique funds management business of Challenger Limited, an ASX-listed investment management firm established in 1985, managing $56.1 billion (as at 30 September 2015).

Since its launch in 2000, Dexion Capital has undertaken 117 transactions, raising more than $18 billion* in partnership with leading investment firms and a wide group of investors across the UK, Europe and US.

Latest Fund Raisings

Pershing Square Holdings, Ltd

Bond issue
Joint bookrunner

Total raised: $1bn


UK core property
Sponsor,financial adviser and sole bookrunner

Total raised: £100.5m

TORO Limited

Sole bookrunner and financial adviser

Total raised: €193m


*As at 1 October 2015, including advisory client mandates and combined AUM where Dexion has acted as joint bookrunner or placing agent.